PMC · DOI:10.1016/j.tjpad.2025.100423·December 1, 2025
What can artificial intelligence bring to Alzheimer’s disease clinical trials? A first perspective
Lefkos T Middleton, Sandrine Andrieu
Abstract
Linked entities
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Diseases1
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsArtificial Intelligence in Healthcare and Education · Dementia and Cognitive Impairment Research · Machine Learning in Healthcare